Skip to main content
Book cover

Syncope pp 27–36Cite as

Epidemiology of Syncope (Fainting)

  • Chapter
  • First Online:
  • 1448 Accesses

Abstract

Transient loss of consciousness (T-LOC) is a common clinical presentation. However, since syncope is only one of several explanations for T-LOC, and it is often unclear whether other causes have been adequately excluded, estimates of the frequency of syncope based on T-LOC occurrences can only be considered an approximation.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Chen LY, et al. Prevalence of syncope in a population aged more than 5 years. Am J Med. 2006;119(1088):e2.

    Google Scholar 

  2. Sheldon RS, Serletis A. Epidemiological aspects of transient loss of consciousness/syncope. In: Benditt DG, et al (eds). Syncope and Transient Loss of Consciousness. A multidisciplinary approach. Oxford: Blackwell Publishing;2007:pp 8–14.

    Chapter  Google Scholar 

  3. Savage DD, et al. Epidemiologic features of isolated syncope: the Framingham Study. Stroke. 1985;16:626–629.

    Article  PubMed  CAS  Google Scholar 

  4. Soteriades ES, et al. Incidence and prognosis of syncope. N Engl J Med. 2002;347:878–885.

    Article  PubMed  Google Scholar 

  5. Ganzeboom KS, et al. Prevalence and triggers of syncope in medical students. Am J Cardiol. 2003;91:1006–1008.

    Article  PubMed  Google Scholar 

  6. Serletis A, et al. Vasovagal syncope in medical students and their first-degree relatives. Eur Heart J. 2006;27:1965–1970.

    Article  PubMed  Google Scholar 

  7. Colivicchi F, et al. Epidemiology and prognostic implications of syncope in young competing athletes. Eur Heart J. 2004;25:1749–1753.

    Article  PubMed  Google Scholar 

  8. Lipsitz LA, et al. Syncope in an elderly, institutionalised population: prevalence, incidence, and associated risk. Q J Med. 1985;55:45–54.

    PubMed  CAS  Google Scholar 

  9. Kenny RA, et al. Impact of a dedicated syncope and falls facility for older adults on emergency beds. Age Ageing. 2002;31:272–275.

    Article  PubMed  Google Scholar 

  10. Kenny RAM, et al. Carotid sinus syndrome: a modifiable risk factor for nonaccidental falls in older adults (SAFE PACE). J Am Coll Cardiol. 2001;38:1491–1496.

    Article  PubMed  CAS  Google Scholar 

  11. Cherin P, et al. Risk of syncope in the elderly and consumption of drugs: A case control study. J Clin Epidemiol. 1997;50:313–320.

    Article  PubMed  CAS  Google Scholar 

  12. Lewis DA, Dhala A. Syncope in the pediatric patient. The cardiologist’s perspective. Pediatr Clin North Am. 1999;46:205–219.

    Article  PubMed  CAS  Google Scholar 

  13. Murdoch BD. Loss of consciousness in healthy South African men: incidence, causes, and relationship to EEG abnormality. S Afr Med J. 1980;57:771–774.

    PubMed  CAS  Google Scholar 

  14. Dermkasian G, Lamb I. Syncope in a population of healthy young adults: incidence, mechanisms, and significance. JAMA. 1958;168:1200–1207.

    Article  Google Scholar 

  15. Feruglio GA, Perraro F. Rilievi epidemiologici sulla sincope nella popolazione generale e come causa di ricovero. G Ital Cardiol. 1987;17(suppl I):11–13.

    Google Scholar 

  16. Sheldon R, et al. Risk factors for syncope recurrence after a positive tilt-table test in patients with syncope. Circulation. 1996;93:973–981.

    Article  PubMed  CAS  Google Scholar 

  17. Middlekauff H, et al. Syncope in advanced heart failure: high risk of sudden death regardless of origin of syncope. J Am Coll Cardiol. 1993;21:110–116.

    Article  PubMed  CAS  Google Scholar 

  18. Martin TP, et al. Risk stratification of patients with syncope. Ann Emerg Med. 1997;29: 459–466.

    Article  PubMed  CAS  Google Scholar 

  19. Kapoor WN, et al. Diagnostic and prognostic implications of recurrences in patients with syncope. Am J Med. 1987;83:700–708.

    Article  PubMed  CAS  Google Scholar 

  20. Pires LA, et al. Comparison of event rates and survival in patients with unexplained syncope without documented ventricular tachyarrhythmias versus patients with documented sustained ventricular tachyarrhythmias both treated with implantable cardioverter-defibrillators. Am J Cardiol. 2000;85:725–728.

    Article  PubMed  CAS  Google Scholar 

  21. Olshansky B, et al. Clinical significance of syncope in the electrophysiologic study versus electrocardiographic monitoring (ESVEM) trial. Am Heart J. 1999;137:878–886.

    Article  PubMed  CAS  Google Scholar 

  22. Steinberg JS, et al. Follow-up of patients with unexplained syncope and inducible ventricular tachyarrhythmias: analysis of the AVID registry and an AVID substudy. Antiarrhythmics Versus Implantable Defibrillators. J Cardiovasc Electrophysiol. 2001;12:996–1001.

    Article  PubMed  CAS  Google Scholar 

  23. Knight BP, et al. Outcome of patients with nonischemic dilated cardiomyopathy and unexplained syncope treated with an implantable defibrillator. J Am Coll Cardiol. 1999;33: 1964–1970.

    Article  PubMed  CAS  Google Scholar 

  24. Olshansky B, et al. Syncope predicts the outcome of cardiomyopathy patients: Analysis of the SCD-HeFT study. J Am Coll Cardiol. 2008;51:1277–1282.

    Article  PubMed  Google Scholar 

  25. Spirito P, et al. Syncope and risk of sudden death in hypertrophic cardiomyopathy. Circulation. 2009;119:1703–1710.

    Article  PubMed  Google Scholar 

  26. Sauer AJ, et al. Long QT syndrome in adults. J Am Coll Cardiol. 2007;49:329–337.

    Article  PubMed  Google Scholar 

  27. Sacher F, et al Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome. A Multicenter Study. Circulation. 2006;114:2317–2324.

    Article  PubMed  Google Scholar 

  28. Sarkozy A, et al Long-term follow-up of primary prophylactic implantable cardioverter-defibrillator therapy in Brugada syndrome. Eur Heart J. 2007;28:334–344.

    Article  PubMed  Google Scholar 

  29. Paul M, et al. Role of programmed ventricular stimulation in patients with Brugada syndrome: a meta-analysis of worldwide published data. Eur Heart J. 2006;28:2126–2133.

    Article  Google Scholar 

  30. Olde Nordkamp LRA, et al. Syncope prevalence in the ED compared to general practice and population: a strong selection process. Am J Emerg Med. 2009;27:271–278.

    Article  PubMed  Google Scholar 

  31. Malasana G, Brignole M, Daccaret M, Sherwood R, Hamdan M. The magnitude of the Faint and Fall Problem in the general population of Utah: a first step towards the creation of a cost-effective diagnostic approach. Pacing Clin Electrophysiol. 2010, Oct 4. doi: 10.1111/j.1540-8159.2010.02930.x. [Epub ahead if print].

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Michele Brignole .

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer-Verlag London Limited

About this chapter

Cite this chapter

Brignole, M., Benditt, D.G. (2011). Epidemiology of Syncope (Fainting). In: Syncope. Springer, London. https://doi.org/10.1007/978-0-85729-201-8_3

Download citation

  • DOI: https://doi.org/10.1007/978-0-85729-201-8_3

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-0-85729-200-1

  • Online ISBN: 978-0-85729-201-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics